About Matchpoint Therapeutics
Matchpoint Therapeutics is a company based in Cambridge (United States) founded in 2021 by Tinghu Zhang, Jianwei Che, Edward Chouchani, and Nathanael Gray. Matchpoint Therapeutics has raised $250 million across 3 funding rounds from investors including ARE, Atlas Venture and Access Industries. The company has 27 employees. Matchpoint Therapeutics offers products and services including Covalent Medicines, Chemoproteomics Platform, and Covalent Library. Matchpoint Therapeutics operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and Dotmatics, among others.
- Headquarter Cambridge, United States
- Employees 27
- Founders Tinghu Zhang, Jianwei Che, Edward Chouchani, Nathanael Gray
- SectorsHealthcare
- Email••••••••
- Website matchpointtx.com
- Social LinkedIn X
- Total Equity Funding$250M (USD)
in 3 rounds
- Latest Funding Round$150M (USD), Series B
Oct 2026
- InvestorsARE
& 11 more
- Employee Count27
Products & Services of Matchpoint Therapeutics
Matchpoint Therapeutics offers a comprehensive portfolio of products and services, including Covalent Medicines, Chemoproteomics Platform, and Covalent Library.
Small molecules targeting proteins in immune diseases for treatment.
Tool for detecting binding pockets in proteins for drug discovery.
Collection of compounds for advancing covalent drug candidates.
Funding Insights of Matchpoint Therapeutics
Matchpoint Therapeutics has successfully raised a total of $250M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $150 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $250M
- Total Rounds 3
- Last Round Series B — $150M
- First Round $30M
(Nov 2021)
- Investors Count 12
All 3 funding rounds of Matchpoint Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2026 | $150M | Series B | – | Nextech Invest, Norwest | |
| Oct 2022 | $70M | Series A | – | Sanofi Ventures | |
| Nov 2021 | $30M | Seed | – | Atlas Venture, Access Industries | – |
12 investors in total: 12 institutional.
Investors in Matchpoint Therapeutics
Matchpoint Therapeutics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Atlas Venture and Access Industries.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in life science and biotechnology sectors | 1980 | atlasventure.com | Cambridge, United States | |
Investment and holding company controlled by Len Blavatnik | – | accessindustries.com | New York, United States | |
Life-Sciences focused Early stage Corporate VC Firm investing in the US | – | sanofiventures.com | Paris, France | |
- | – | vertexventureshc.com | - | |
Digitalis Ventures is engaged in health-focused investments. | – | digitalisventures.com | New York, United States | |
- | – | nextechinvest.com | - | |
- | – | norwest.com | - | |
- | – | invus.com | - | |
- | – | bbbiotech.ch | - | |
- | – | t1dfund.org | - |
Investor details for Matchpoint Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Matchpoint Therapeutics
17 people are tracked at Matchpoint Therapeutics (14 in leadership, 3 in team); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Tinghu Zhang | Co-Founder | Leadership |
Jianwei Che | Co-Founder | Leadership |
Edward Chouchani | Co-Founder | Leadership |
Nathanael Gray | Co-Founder | Leadership |
Andre Turenne | CEO | Leadership |
M. Paola Castaldi | Senior Vice President, Head of Platform and Chemical Biology | Leadership |
Al Nadar | Sr. Director Research Operations | Leadership |
Jared Cumming | Chief Scientific Officer | Leadership |
Christopher Hren | Senior Vice President, Business Operations | Leadership |
Suresh Singh | Senior Vice President, Computational Sciences | Leadership |
Mark Jedrychowski, PhD | Senior Director and Head of Proteomics | Leadership |
James Holland | Controller, Senior Director Finance | Leadership |
Raj Iyengar | Vice President, Medicinal Chemistry | Leadership |
Wei Li | Vice President, Biology at Matchpoint Therapeutics | Leadership |
Jennifer Alley | Senior Principal Scientist at Matchpoint Therapeutics | Team |
Hiroto Kambara, Ph.D. | Senior Principal Scientist | Team |
Joshua Grady, PhD | Principal Scientist, Chemoproteomics | Team |
Complete people profiles for Matchpoint Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Matchpoint Therapeutics
3 dated milestones of Matchpoint Therapeutics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Matchpoint Therapeutics is founded.
- Funding First funding round of $30.0M.
- Funding Latest funding round, Series B, of $150.0M.
Competitors of Matchpoint Therapeutics
Matchpoint Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and Dotmatics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmaron.com | 2003 | Beijing, China | $320M | 476 | Drug discovery and development services for small molecules are provided. | |
| lonza.com | 1897 | Basel, Switzerland | $100,000 | 14,500 | CDMO services for pharma, biotech, and specialty ingredients are provided. | |
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| boehringer-ingelheim.com | 1885 | – | – | 31 | Generic drugs and clinical research services are provided globally. | |
| dotmatics.com | 2005 | – | $11.34M | 512 | AI powered scientific data management and workflow automation solutions | |
| labconnect.com | 2002 | Johnson, United States | $28.5M | – | Laboratory testing, clinical trial research, and biopharma services are provided. | |
| ainos.com | 1986 | San Diego, United States | – | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. | |
| biomatter.ai | 2018 | Vilnius, Lithuania | $7.73M | – | Provider of synthetic biology and AI-based technology for generative protein design | |
| betadrugslimited.com | 2005 | Panchkula, India | – | 637 | Developer of therapeutics for oncology and dermatology |
Detailed competitors of Matchpoint Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Matchpoint Therapeutics
The website of Matchpoint Therapeutics (matchpointtx.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 0.8% vs previous month
Latest news on Matchpoint Therapeutics
Complete news archive for Matchpoint Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Matchpoint Therapeutics
10 companies that operate in the same segment as Matchpoint Therapeutics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Matchpoint Therapeutics
Matchpoint Therapeutics was founded in 2021.
Matchpoint Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Andre Turenne is the current CEO of Matchpoint Therapeutics.
Matchpoint Therapeutics is a funded company, having raised a total of $250M across 3 funding rounds to date. The company's 1st funding round was a Seed of $30M, raised on Nov 2021.
Matchpoint Therapeutics has 27 employees.
Matchpoint Therapeutics was established in 2021 in Cambridge, United States, within the biotechnology sector. Small molecule medicines are developed, and analytics services are offered to support therapeutic advancements. The company operates from its base in the U.S., focusing on precision medicine solutions. Co-founders Tinghu Zhang, Jianwei Che, Edward Chouchani, and Nathanael Gray lead the scientific efforts, while Andre Turenne serves as CEO. Core activities emphasize data-driven drug discovery processes.
Matchpoint Therapeutics offers Covalent Medicines, Chemoproteomics Platform, and Covalent Library.
Matchpoint Therapeutics has 12 investors. Key investors include ARE, Atlas Venture, Access Industries, Sanofi Ventures, and Vertex Ventures HC.